The ClearBlood
Immune Panel

Measures your immune response to the spike protein — from either vaccination or infection. Elevated levels months after exposure may indicate persistent immune activation.

Distinguishes natural infection from vaccine response. Nucleocapsid antibodies are only produced after actual COVID infection, not from mRNA vaccines.

The primary biomarker for microclot formation and blood clotting activity. Elevated D-dimer is one of the most consistent findings in Long COVID and post-vaccine syndrome patients.

Measures systemic inflammation with high precision. Even mildly elevated hsCRP is associated with cardiovascular risk and ongoing immune activation.

A clotting protein that is frequently elevated in patients with spike protein exposure. Elevated fibrinogen contributes to the hypercoagulable state seen in Long COVID.

Screens for autoimmune activity. Post-COVID and post-vaccine autoimmune conditions are well-documented in peer-reviewed literature. A positive ANA warrants follow-up testing.

Assesses liver function, kidney function, electrolytes, and blood glucose. Provides a comprehensive baseline for organ health and metabolic status.

Complete blood count with immune cell breakdown. Identifies abnormalities in white blood cell populations, red blood cells, and platelets — all relevant to immune health.

An iron storage protein that also functions as an acute-phase reactant. Elevated ferritin is a marker of inflammation and immune activation, commonly seen in Long COVID.

Vitamin D deficiency is strongly associated with immune dysfunction and worse COVID outcomes. Optimizing Vitamin D is one of the first interventions in most post-COVID protocols.